EverSource Wealth Advisors’s Mirum Pharmaceuticals MIRM Stock Holding History

EverSource Wealth Advisors’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$34.4K	Sell	294 -42	-13%	-$4.22K	﹤0.01%	2030
2026 Q1	$31K	Sell	336 -114	-25%	-$10.7K	﹤0.01%	2227
2025 Q4	$35.5K	Sell	450 -12	-3%	-$861	﹤0.01%	1990
2025 Q3	$33.9K	Buy	462 +29	+7%	+$1.84K	﹤0.01%	1983
2025 Q2	$22K	Buy	433 +53	+14%	+$2.36K	﹤0.01%	2217
2025 Q1	$17.1K	Buy	380 +15	+4%	+$707	﹤0.01%	1779
2024 Q4	$15.1K	Hold	365	–	–	﹤0.01%	1782
2024 Q3	$14.2K	Hold	365	–	–	﹤0.01%	1665
2024 Q2	$14.8K	Buy	365 +95	+35%	+$2.49K	﹤0.01%	1664
2024 Q1	$6.78K	Hold	270	–	–	﹤0.01%	1890
2023 Q4	$7.97K	Buy	270 +30	+13%	+$908	﹤0.01%	1666
2023 Q3	$7.58K	Buy	+240	New	+$6.57K	﹤0.01%	1528

Other funds holding MIRM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

NFT

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

EverSource Wealth Advisors's MIRM Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Mirum Pharmaceuticals (MIRM) stake by 13% in Q2 2026, selling an estimated $4.22K and leaving 294 shares worth $34.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2030.

EverSource Wealth Advisors first reported a position in MIRM in Q3 2023 and has held it in 12 quarters since. The position peaked at $35.5K in Q4 2025. 101 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

EverSource Wealth Advisors held 294 shares of Mirum Pharmaceuticals worth $34.4K as of Q2 2026.
EverSource Wealth Advisors sold 42 Mirum Pharmaceuticals shares in Q2 2026, an estimated $4.22K.
Mirum Pharmaceuticals made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #2030 holding.
EverSource Wealth Advisors first reported a position in Mirum Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
EverSource Wealth Advisors's Mirum Pharmaceuticals position peaked at $35.5K in Q4 2025.
101 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.